Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 1-Oct-2019 10:05 AM EDT
Texas Biomed Awarded $2.8 Million NIH Grant for Novel TB Research
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute are zeroing in on a new way to target tuberculosis (TB) infection. The National Institutes of Health (NIH) has awarded a four-year, $2.8 million grant for scientists to study the role of lung macrophages (immune cells) in metabolic and inflammation responses to TB.

Released: 1-Oct-2019 5:05 AM EDT
What You Need to Know About Sinus Infections
University of Alabama at Birmingham

As the fall months approach, the potential for seasonal allergies, runny noses and sinus infections increases.

Released: 30-Sep-2019 4:30 PM EDT
Researchers Publish Comprehensive Review on Respiratory Effects of Vaping
University of North Carolina School of Medicine

Studies show measurable adverse biologic effects on lung health and cells in humans, in animals, and in tissue samples studied in the lab. The effects of e-cigarettes have similarities to those seen in traditional cigarettes and important differences

Released: 30-Sep-2019 1:05 PM EDT
Advertencia del experto: Experto de Mayo Clinic trata inquietudes acerca de vapear
Mayo Clinic

Dado que las posibles muertes por vapear dominan los titulares en las noticias, han surgido más inquietudes respecto a sus efectos y a las enfermedades pulmonares relacionadas con esta práctica.

Released: 30-Sep-2019 11:05 AM EDT
Duke Vaccine Institute Plays Integral Role in National Effort to Improve Flu Shots
Duke Clinical Research Institute

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases (NIAID), with an initial award of approximately $29.6 million in first-year funding.

30-Sep-2019 6:00 AM EDT
AI System Accurately Detects Key Findings in Chest X-Rays of Pneumonia Patients Within 10 Seconds: Study Finds Promise of Faster Treatment
Intermountain Healthcare

From 20 minutes or more to 10 seconds. Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they studied that utilizes artificial intelligence took to accurately identify key findings in chest X-rays of patients in the emergency department suspected of having pneumonia.

Released: 30-Sep-2019 9:00 AM EDT
Nanoparticles Wiggling Through Mucus May Predict Severe COPD
Johns Hopkins Medicine

In a proof-of-concept experiment, researchers from Johns Hopkins Medicine say they have successfully used microscopic man-made particles to predict the severity of patients’ chronic obstructive pulmonary disease (COPD) by measuring how quickly the particles move through mucus samples. The technique, say the researchers, could eventually help doctors deliver more effective treatments sooner.

Released: 30-Sep-2019 7:00 AM EDT
Women with Asthma Appear More Likely to Have Lower Levels of Testosterone
American Thoracic Society (ATS)

Women with asthma appear more likely to have lower levels of “free” (not attached to proteins) testosterone than women who do not have asthma, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

25-Sep-2019 9:15 AM EDT
Wrist-Worn Step Trackers are as Accurate in Predicting Patient Health as Standardized Clinical Walking Tests, Researchers Find
Intermountain Healthcare

In a new study, researchers at Intermountain Healthcare in Salt Lake City found that steps measured through a step tracker worn on the wrist can be used to estimate exercise capacity and determine the health status of patients, rather than the standardized six-minute walk distance test, which is usually conducted in a clinical setting.

Released: 27-Sep-2019 12:00 PM EDT
Researchers show genetic mutations in advanced lung cancer may predict improved outcomes
Yale Cancer Center/Smilow Cancer Hospital

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

Released: 27-Sep-2019 11:05 AM EDT
Researchers seek microbial link between two common and costly respiratory diseases
Northern Arizona University

The NIH awarded Northern Arizona University professors Emily Cope and Greg Caporaso a $468,472 grant to study how microbiota in the upper and lower airways drive inflammation in patients with asthma and chronic rhinosinusitis.

26-Sep-2019 6:05 PM EDT
Study Shows Nearly Half of Cancer Patients Who Enter a Comprehensive Tobacco Treatment Program Quit Smoking
University of Texas MD Anderson Cancer Center

In the largest smoking cessation study of cancer patients to date, researchers from The University of Texas MD Anderson Cancer Center found that comprehensive tobacco treatment can help cancer patients successfully quit and abstain from smoking.

Released: 26-Sep-2019 11:05 AM EDT
Adding radiation after immunotherapy improves progression-free survival for some patients with metastatic lung cancer
American Society for Radiation Oncology (ASTRO)

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer (NSCLC), increasing progression-free survival (PFS). Findings of the phase II randomized trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

25-Sep-2019 3:05 PM EDT
Investigational Drug with Immunotherapy May Provide New Therapeutic Opportunity for Patients Previously Treated for Kidney and Lung Cancer
University of Texas MD Anderson Cancer Center

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase IB study

24-Sep-2019 3:45 PM EDT
Common TB Vaccine May Lower Lung Cancer Risk
Uniformed Services University of the Health Sciences (USU)

A common tuberculosis (TB) vaccine could decrease the risk of lung cancer if administered during early childhood, according to a study published Sept. 25 in JAMA Network Online.

Released: 25-Sep-2019 7:00 AM EDT
World Lung Day 2019: Respiratory Groups Unite to Call for Healthy Lungs for All
American Thoracic Society (ATS)

Today, on World Lung Day (WLD), the American Thoracic Society is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health.

Released: 23-Sep-2019 2:05 PM EDT
WORLD LUNG DAY 2019: Rutgers Docs Raise Awareness, Develop Solutions for Emerging Public Health Crises
Rutgers University-New Brunswick

On September 25, 2019, Rutgers New Jersey Medical School (NJMS) will mark World Lung Day, an international day for lung health advocacy and action.

Released: 23-Sep-2019 9:35 AM EDT
Vaping and Your Health: Here’s What You Need to Know
Beth Israel Lahey Health

Jennifer Wilson, MD. a thoracic surgeon at Beth Israel Deaconess Medical Center, discusses vaping and your health



close
2.54215